Drug giant Pfizer, Inc. (NYSE: PFE) reported Q4 results before the bell on Tuesday, with EPS topping expectations, though full-year ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE